- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01097993
A Single-centre, Randomised, Double-blind, Controlled, Parallel-group Study to Evaluate the Effect of a Fermented Dairy Product on Abdominal Distension, Digestive Symptoms and Rectal Sensitivity in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
January 18, 2017 updated by: Danone Research
The purpose of this study is to evaluate the effect of a commercially available fermented dairy product containing probiotics (4 weeks, twice a day) on abdominal distension in IBS patients with constipation (IBS-C).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Manchester, United Kingdom
- Manchester Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- female
- Age: 18-70
Exclusion Criteria:
- NA
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1 = Tested product
|
Arm 1 - Intervention 1 (probiotics)
|
Active Comparator: 2 = Control product
|
Arm 2 - Intervention 2 (control)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean abdominal distension after a 4-week period of product consumption in IBS-C patients
Time Frame: 0-4 weeks
|
0-4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
March 29, 2010
First Submitted That Met QC Criteria
April 1, 2010
First Posted (Estimate)
April 2, 2010
Study Record Updates
Last Update Posted (Estimate)
January 20, 2017
Last Update Submitted That Met QC Criteria
January 18, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- NU324
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Women With IBS-C
-
NovartisCompletedIBS-C and IBS With Mixed Bowel Habits
-
Halic UniversityCompletedWomen With Low Sexual Satisfaction | Partners of Women With Low Sexual SatisfactionTurkey
-
Tehran University of Medical SciencesUnknownWomen With PMSIran, Islamic Republic of
-
Clinique OvoWithdrawnEffect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro FertilizationWomen With Fertility DisorderCanada
-
Sheba Medical CenterUnknownWomen With Poor Ovarian ResponseIsrael
-
Synthetic Biologics Inc.CompletedIrritable Bowel Syndrome With Constipation (IBS-C)United States
-
Augusta UniversityForest LaboratoriesCompletedIrritable Bowel Syndrome With Constipation (IBS-C)United States
-
Glicksman, Caroline, M.D.The Aesthetic Surgery Education & Research FoundationActive, not recruitingWomen With Breast Implants With and Without Self-reported Systemic Symptoms | Women Undergoing an Elective Mastopexy (Breast Lift) or Small ReductionUnited States
-
KU LeuvenRecruitingHealthy Controls | IBS | Ulcerative Colitis, Active | Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms) | Crohn's Disease, Active | Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)Belgium
-
Karolinska InstitutetCompletedNulliparous Women With Prolonged Latent PhaseSweden
Clinical Trials on 1-fermented dairy product
-
Danone ResearchCompletedHealthy Free-living ElderlyBelgium
-
Danone ResearchCompletedHealthy Adult WomenUnited States
-
Danone ResearchCompletedHealthyBelgium, France, Spain, United Kingdom
-
Danone ResearchCompletedHealthy Adult WomenFrance
-
Danone ResearchCompleted
-
Danone JapanCompleted
-
Danone JapanCompletedSubjects With High LDL-CholesterolJapan
-
Danone ResearchCompletedCommon Infectious DiseasesRussian Federation
-
Danone ResearchTerminatedGastroenteritis | Sinusitis | Otitis | Bronchitis | Upper Respiratory Tract Infections | Sore Throat | Flu | Lower Respiratory Tract Infections | Rhinopharyngitis | Pneumopathy | Flu-like SyndromesFrance
-
Hospital Clinico Universitario de SantiagoMinisterio de Economía y Competitividad, SpainCompleted